Aileron Therapeutics Announces a 1-for-20 Reverse Stock Split

(marketscreener.com) Common Stock Will Begin Trading on Split-Adjusted Basis on November 11, 2022BOSTON, Nov. 10, 2022 -- Aileron Therapeutics , a chemoprotection oncology company that aspires to make chemotherapy safer and thereby more effective to save more patients’ lives, today announced that it will effect a 1-for-20 reverse stock split of its common...https://www.marketscreener.com/quote/stock/AILERON-THERAPEUTICS-INC-35952881/news/Aileron-Therapeutics-Announces-a-1-for-20-Reverse-Stock-Split-42270438/?utm_medium=RSS&utm_content=20221110